Oct 7 – Oct 10, 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Dec 3, 2020 8:00 am EST Key Opinion Leader Webcast on the Ovarian Cancer Treatment Landscape and Data Highlights from the Phase 2 Trial of a Novel T-Cell Therapy
Nov 23, 2020 11:00 am EST National Capital Markets Virtual Panel: “Covid-19, a shot in the arm for Canadian Biotech”
Nov 12, 2020 8:00 am EST Company Webcast - Biomarkers Associated With Clinical Response in Patients With r/r DLBCL Treated With DPX-Survivac Combination Therapy and review of Q3 earnings and highlights
Feb 27, 2020 8:30 am EST Key Opinion Leader Symposium on Role of Survivin in Cancer Biology and Potential of DPX-Survivac
Feb 25, 2020 8:00 am EST Conference Call & Webcast To Report Updated Results Of Phase 2 DeCidE1 Study
Dec 9, 2019 8:00 am EST Clinical update on Investigator-initiated SPiReLPhase 2 with Merck’s Keytruda® in relapse/refractory Diffuse Large B-cell Lymphoma (r/r DLBCL)
